No images? Click here
Oxford Health BRC Newsletter Issue 10
Welcome to the November 2024 issue of the Oxford Health Biomedical Research Centre (OH BRC) newsletter which summarises all recently published news and updates in one place.
To feature in future editions email Oxford Health R&D Comms
Research in the News
- Riccardo De Giorgi - Semaglutide and mental health The Guardian
- OH CRF launches new website - Oxford Mail
- Debbie Moll - The SOCIAL study Broadcast Retirement Network
- OH CRF COMPASS study - Oxford Mail
GPs supported to help patients with depression through 7 new specialist clinics across the UK
The NIHR and Office for Life Sciences (OLS) have invested £18 million into specialist clinics enabling GPs to support more patients with difficult to treat depression. These new clinics build on an existing network of research clinics, including the Oxford Health Biomedical Research Centre’s Treatment Resistant Depression Clinic, who work with world-leading researchers on depression.
Read more: OH BRC news
NIHR BRC and CRF Inclusion Conference
Birmingham's Biomedical Research Centre (BBRC) and Clinical Research Facility (BCRF) hosted the first Biomedical Research Centre (BRC) and Clinical Research Facility (CRF) Inclusion Conference last month. OH BRC and OH CRF were represented at the event, with Clinical Research Facilitators Rachel Delahey and Shun-Yan-Toto presenting on their encouragement of research participants to complete demographic questionnaires on arrival at their research appointment.
Read more: OH BRC News
The Oxford-Toronto Collaboration
Recently, delegates from Oxford Health NHS Foundation Trust, the UoO Department of Psychiatry and our BRC Data Science Theme visited the Centre for Addiction and Mental Health in Toronto as part of the Oxford-Toronto Collaboration.
Particular highlights were the visit to the Krembil Centre for Neuroinformatics and discussion about how to work together and advance data science and precision mental health, with a specific focus on health informatics and AI, risk prediction and suicide prevention. We would like to thank our hosts for their hospitality, and we look forward to continuing our collaboration in 2025
Email Anthony Quinn for more information
New research explores link between COVID-19 hospitalisation and cognitive impairment
New research, supported by our BRC Molecular Targets Theme Co-Leads Professors Paul Harrison and Rachel Upthegrove and BRC Dementia Theme Co-Lead Professor Masud Husain, has found that patients who were hospitalised with COVID-19 showed higher levels of cognitive impairment.
Read more: OH BRC News
New study for Treatment-Resistant Depression at OH CRF
The NIHR Oxford Health Clinical Research Facility (OH CRF) has begun researching a new potential drug treatment for Treatment-Resistant Depression (TRD). The study will help to show whether COMP360, a synthetically produced formulation of psilocybin is effective and, if so, how long that effect might last.
Read more: OH CRF News
Research colleagues host coffee afternoon
Recently, research colleagues came together to host a Research Coffee Afternoon at Buckinghamshire New University in Aylesbury to engage the university’s students, staff and visiting members of the public in health care research, informally over a cup of coffee and cake.
Read more: OH BRC News
60 seconds with…. Oxford Health Clinical Research Facility (OH CRF) Team Lead Debbie Moll
Debbie Moll, newly appointed CRF Team Lead, spoke about her career in research in a "60 second interview".
Debbie previously worked as a researcher in the Oxford Health NHS Foundation Trust’s Memory and Cognition Research Delivery Team
Read more: OH CRF
NIHR LCRN is now NIHR South Central RRDN
The NIHR Clinical Research Network (CRN) Thames Valley & South Midlands is now the NIHR South Central Regional Research Delivery Network (RRDN). This will continue to support research delivery in Berkshire, Buckinghamshire, Isle of Wight, Hampshire and Oxfordshire.
Read more: NIHR South Central Regional Research Delivery Network
Lifetime cannabis use is associated with several aspects of brain structure and function in later life but cannabis use may not be the cause of these changes, according to a new study by researchers at Oxford Population Health and the Department of Psychiatry.
Read More: DoP News
Study charts course for next generation of drug targets in autoimmune diseases
A major problem faced by the autoimmune diseases community is that current drugs do not work for every patient and clinicians do not know why. Auto immune diseases such as inflammatory bowel diseases, which include Crohn’s disease and ulcerative colitis affect a large number of the global population. In a world first, researchers in Oxford have discovered why some patients benefit from certain drugs while others do not.
Read more: Oxford Biomedical Research Centre News
